The board of directors of Hua Medicine (Shanghai) Ltd. announced that Mr. Junling Liu has tendered his resignation as an independent non-executive Director and a member of the Board's remuneration committee, nomination committee and strategy committee with effect from March 31, 2023, due to his involvement in a business with growing potential dealings with the Company and has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited. Following the resignation of Mr. Liu and with effect from March 31, 2023, (i) Mr. Yiu Wa Alec Tsui, an independent non-executive Director of the Company, will be appointed as a member of the Nomination Committee, (ii) Ms. Wei Zhao, a non-executive Director of the Company, will be appointed as a member of the Remuneration Committee, and (iii) Mr. George Chien Cheng Lin, an executive Director of the Company, will be appointed as a member of the Strategy Committee.